| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gene Therapy Program [C. K. G., B. E. R., J. T. D., D. T. C.] and Departments of Pathology, Cell Biology, and Surgery [G. P. S.], University of Alabama at Birmingham, Birmingham, Alabama 35294, Prizm Pharmaceuticals, San Diego, California 92121 [B. A. S., W. Y., A. B.], and University of Colorado Health Sciences Center, Denver, Colorado 80262 [J. A. C.]
Kaposi's sarcoma (KS) is a major AIDS-related malignancy associated with significant morbidity and mortality. Current chemotherapeutic regimens are associated with a dismal prognosis. In an effort to develop a new approach to KS treatment, we devised a gene therapy-based adenovirus retargeting schema that redirects the adenovirus to fibroblast growth factor receptors endogenously present on the cell surface of KS cells. By using a bifunctional conjugate consisting of a blocking antiadenoviral knob Fab linked to basic fibroblast growth factor, FGF2, the gene transduction of KS cells was enhanced 7.7–44 fold; recombinant adenoviruses encoding either the firefly luciferase reporter gene, or the herpes simplex thymidine kinase gene, demonstrated quantitative enhancement of expression in the KS cell lines. In this regard, two KS cell lines that were previously refractory to native adenovirus transduction could be successfully transduced by the addition of the conjugate. This study thus addresses the utility of adenoviral retargeting to the FGF receptor in KS cells that are ordinarily transduction refractory to standardized approaches and allows practical development of gene therapy approaches for the treatment of human KS.
1 This work was supported by NIH Grant 5P30-CA1314A-25, United States Army Grant DAMD-17-94-54398, the Lymphoma Research Foundation, and in part by the Daland Fellowship Program at the American Philosophical Foundation and the Southern Medical Association.
2 To whom requests for reprints should be addressed, at Gene Therapy Program, University of Alabama at Birmingham, 1824 6th Avenue South, WTI 620, Birmingham, AL 35294. Phone: (205) 934-8627; Fax: (205) 975-7476; E-mail: david.curiel@ccc.uab.edu.
Received 2/ 3/97. Accepted 2/28/97.
This article has been cited by other articles:
|
|
 |
|
  H.-J. Li, M. Everts, L. Pereboeva, S. Komarova, A. Idan, D. T. Curiel, and H. R. Herschman Adenovirus Tumor Targeting and Hepatic Untargeting by a Coxsackie/Adenovirus Receptor Ectodomain Anti-Carcinoembryonic Antigen Bispecific Adapter Cancer Res., June 1, 2007; 67(11): 5354 - 5361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Al-Hendy and S. Salama Gene therapy and uterine leiomyoma: a review Hum. Reprod. Update, July 1, 2006; 12(4): 385 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Qin, B. Escuadro, S. Sharma, and R. K. Batra Gene Transfer Mediated by Native versus Fibroblast Growth Factor-Retargeted Adenoviral Vectors into Lung Cancer Cells Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 211 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gomez-Manzano, W.K. A. Yung, R. Alemany, and J. Fueyo Genetically modified adenoviruses against gliomas: From bench to bedside Neurology, August 10, 2004; 63(3): 418 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Rux, P. R. Kuser, and R. M. Burnett Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods J. Virol., September 1, 2003; 77(17): 9553 - 9566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, T. Smith, N. Idamakanti, K. Mulgrew, M. Kaloss, H. Kylefjord, P. C. Ryan, M. Kaleko, and S. C. Stevenson Targeting Adenoviral Vectors by Using the Extracellular Domain of the Coxsackie-Adenovirus Receptor: Improved Potency via Trimerization J. Virol., February 15, 2002; 76(4): 1892 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Seki, I. Dmitriev, E. Kashentseva, K. Takayama, M. Rots, K. Suzuki, and D. T. Curiel Artificial Extension of the Adenovirus Fiber Shaft Inhibits Infectivity in Coxsackievirus and Adenovirus Receptor-Positive Cell Lines J. Virol., February 1, 2002; 76(3): 1100 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. DeGroot and R. Zhang CLINICAL REVIEW 131: Gene Therapy for Thyroid Cancer: Where Do We Stand? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2923 - 2928. [Full Text] [PDF]
|
|
|
|
 |
|
 L S YOUNG and V MAUTNER The promise and potential hazards of adenovirus gene therapy Gut, May 1, 2001; 48(5): 733 - 736. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Jakubczak, M. L. Rollence, D. A. Stewart, J. D. Jafari, D. J. Von Seggern, G. R. Nemerow, S. C. Stevenson, and P. L. Hallenbeck Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells J. Virol., March 15, 2001; 75(6): 2972 - 2981. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ebbinghaus, A. Al-Jaibaji, E. Operschall, A. Schöffel, I. Peter, U. F. Greber, and S. Hemmi Functional and Selective Targeting of Adenovirus to High-Affinity Fc{gamma} Receptor I-Positive Cells by Using a Bispecific Hybrid Adapter J. Virol., January 1, 2001; 75(1): 480 - 489. [Abstract] [Full Text]
|
|
|
|
|
|
V. Krasnykh, I. Dmitriev, J.-G. Navarro, N. Belousova, E. Kashentseva, J. Xiang, J. T. Douglas, and D. T. Curiel Advanced Generation Adenoviral Vectors Possess Augmented Gene Transfer Efficiency Based upon Coxsackie Adenovirus Receptor-independent Cellular Entry Capacity Cancer Res., December 1, 2000; 60(24): 6784 - 6787. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. J. Kelly, C. R. Miller, D. J. Buchsbaum, J. Gomez-Navarro, M. N. Barnes, R. D. Alvarez, and D. T. Curiel Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells versus Autologous Mesothelial Cells in Vitro Clin. Cancer Res., November 1, 2000; 6(11): 4323 - 4333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Dmitriev, E. Kashentseva, B. E. Rogers, V. Krasnykh, and D. T. Curiel Ectodomain of Coxsackievirus and Adenovirus Receptor Genetically Fused to Epidermal Growth Factor Mediates Adenovirus Targeting to Epidermal Growth Factor Receptor-Positive Cells J. Virol., August 1, 2000; 74(15): 6875 - 6884. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. A. Nicklin, S. J. White, S. J. Watkins, R. E. Hawkins, and A. H. Baker Selective Targeting of Gene Transfer to Vascular Endothelial Cells by Use of Peptides Isolated by Phage Display Circulation, July 11, 2000; 102(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Von Seggern, S. Huang, S. K. Fleck, S. C. Stevenson, and G. R. Nemerow Adenovirus Vector Pseudotyping in Fiber-Expressing Cell Lines: Improved Transduction of Epstein-Barr Virus-Transformed B Cells J. Virol., January 1, 2000; 74(1): 354 - 362. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kasono, J. L. Blackwell, J. T. Douglas, I. Dmitriev, T. V. Strong, P. Reynolds, D. A. Kropf, W. R. Carroll, G. E. Peters, R. P. Bucy, et al. Selective Gene Delivery to Head and Neck Cancer Cells via an Integrin Targeted Adenoviral Vector Clin. Cancer Res., September 1, 1999; 5(9): 2571 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Smith, J. R. Keller, N. C. Lohrey, C. S. McCauslin, M. Ortiz, K. Cowan, and S. E. Spence Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens PNAS, August 3, 1999; 96(16): 8855 - 8860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. DOUKAS, D. K. HOGANSON, M. ONG, W. YING, D. L. LACEY, A. BAIRD, G. F. PIERCE, and B. A. SOSNOWSKI Retargeted delivery of adenoviral vectors through fibroblast growth factor receptors involves unique cellular pathways FASEB J, August 1, 1999; 13(11): 1459 - 1466. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. L. Blackwell, C. R. Miller, J. T. Douglas, H. Li, P. N. Reynolds, W. R. Carroll, G. E. Peters, T. V. Strong, and D. T. Curiel Retargeting to EGFR Enhances Adenovirus Infection Efficiency of Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, August 1, 1999; 125(8): 856 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Miyazawa, P. L. Leopold, N. R. Hackett, B. Ferris, S. Worgall, E. Falck-Pedersen, and R. G. Crystal Fiber Swap between Adenovirus Subgroups B and C Alters Intracellular Trafficking of Adenovirus Gene Transfer Vectors J. Virol., July 1, 1999; 73(7): 6056 - 6065. [Abstract] [Full Text]
|
|
|
|
|
|
D.-l. Gu, A. M. Gonzalez, M. A. Printz, J. Doukas, W. Ying, M. D'Andrea, D. K. Hoganson, D. T. Curiel, J. T. Douglas, B. A. Sosnowski, et al. Fibroblast Growth Factor 2 Retargeted Adenovirus Has Redirected Cellular Tropism: Evidence for Reduced Toxicity and Enhanced AntitumorActivity in Mice Cancer Res., June 1, 1999; 59(11): 2608 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Tillman, T. D. d. Gruijl, S. A. L.-d. Bakker, R. J. Scheper, H. M. Pinedo, T. J. Curiel, W. R. Gerritsen, and D. T. Curiel Maturation of Dendritic Cells Accompanies High-Efficiency Gene Transfer by a CD40-Targeted Adenoviral Vector J. Immunol., June 1, 1999; 162(11): 6378 - 6383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. LAROCCA, P. D. KASSNER, A. WITTE, R. C. LADNER, G. F. PIERCE, and A. BAIRD Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage FASEB J, April 1, 1999; 13(6): 727 - 734. [Abstract] [Full Text]
|
|
|
|
|
|
V. Legrand, D. Spehner, Y. Schlesinger, N. Settelen, A. Pavirani, and M. Mehtali Fiberless Recombinant Adenoviruses: Virus Maturation and Infectivity in the Absence of Fiber J. Virol., February 1, 1999; 73(2): 907 - 919. [Abstract] [Full Text]
|
|
|
|
|
|
B. E. Rogers, S. F. McLean, R. L. Kirkman, D. Della Manna, S. J. Bright, C. C. Olsen, A. D. Myracle, M. S. Mayo, D. T. Curiel, and D. J. Buchsbaum In Vivo Localization of [111In]-DTPA-D-Phe -Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector Clin. Cancer Res., February 1, 1999; 5(2): 383 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Murakami-Mori, S. Mori, and S. Nakamura Endogenous Basic Fibroblast Growth Factor Is Essential for Cyclin E-CDK2 Activity in Multiple External Cytokine-Induced Proliferation of AIDS-Associated Kaposi's Sarcoma Cells: Dual Control of AIDS-Associated Kaposi's Sarcoma Cell Growth and Cyclin E-CDK2 Activity by Endogenous and External Signals J. Immunol., August 15, 1998; 161(4): 1694 - 1704. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
